Professor Eileen McLaughlin’s career began at the University of Bristol (1987-1997) in male reproduction, followed by a Wellcome Trust-funded fellowship in molecular genetics of male fertility (1997-2000). She later lectured in Obstetrics and Gynaecology before moving to CSIRO Australia, where she developed immunocontraceptives for pest control.
Her research spans germ cell development, fertility, environmental toxicants, and novel contraceptive therapies. She has published over 170 articles, with over 10,000 citations (H-index 60), and secured more than $76 million in research funding. Her work appears in prestigious journals like Cell, PNAS, The Lancet, and Cell Stem Cell.
Professor McLaughlin has supervised 31 PhD, Masters, and Honours students and taught extensively in biomedicine and biology. She has served on panels for the ARC, NHMRC, and the Irish Research Council and is currently a member of the ARC Medical Research Advisory Group.
Since 2002, she has held key roles at the University of Newcastle, University of Auckland, University of Canberra, and Western Sydney University. She has been Chair of the British Andrology Society and the Society for Reproductive Biology and has held leadership roles in numerous professional bodies.
Her accolades include the British Fertility Society FSA Prize, RCRH Award for Research Excellence, the Setchell Medal, and the SRB Presidents Medal, reflecting the significant impact of her research.
